Webinar Video | Life Sciences Session #2: Vaccine liability: what if vaccination goes wrong?

Webinar Video | Life Sciences Session #2: Vaccine liability: what if vaccination goes wrong?
January 26, 2021

The ongoing vaccination campaign against Covid-19 raises the question of possible side effects and of the potential liability for damages arising from the use of vaccines used against this disease. Christophe Ronse and Lauranne Truyens highlight and discuss the various legal issues arising in such context, both from a regulatory and from a civil law viewpoint.

Contact

  • Christophe Ronse

    Partner

  • Lauranne Truyens

    Managing Associate

Recommended articles

August 10, 2026

Belgian Pharma Law Summer Blog Series (Part 3): the recently passed ‘Bill containing various provisions on health’

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Our third and final part examines the ‘Bill containing […]

Read on
August 03, 2026

Belgian Pharma Law Summer Blog Series (Part 2): the new ‘Article 10 guidance’ on pharmaceutical promotion

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Part 2 focuses on the new guidance on the […]

Read on
July 27, 2026

Belgian Pharma Law Summer Blog Series (Part 1): the Act of 30 May 2026 containing various provisions on medicinal and health products

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Part 1 focuses on the Act of 30 May […]

Read on